Outcome of intracerebral haemorrhage related to non-vitamin K antagonists oral anticoagulants versus vitamin K antagonists: a comprehensive systematic review and meta-analysis

被引:34
作者
Boulouis, Gregoire [1 ]
Morotti, Andrea [2 ]
Pasi, Marco [3 ,4 ]
Goldstein, Joshua N. [3 ,4 ,5 ]
Gurol, M. Edip [3 ,4 ]
Charidimou, Andreas [3 ,4 ]
机构
[1] Univ Paris 05, Ctr Hosp St Anne, Dept Neuroradiol, Paris, Ile De France, France
[2] C Mondino Natl Neurol Inst, Stroke Unit, Dept Emergency Neurol, Pavia, Italy
[3] Massachusetts Gen Hosp, Dept Hemorrhag Stroke Res Grp, Boston, MA 02114 USA
[4] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02114 USA
[5] Harvard Med Sch, Massachusetts Gen Hosp, Div Neurocrit Care & Emergency Neurol, Boston, MA 02114 USA
关键词
ATRIAL-FIBRILLATION PATIENTS; INTRACRANIAL HEMORRHAGE; RADIOLOGICAL COURSE; HEMATOMA VOLUME; WARFARIN; DABIGATRAN; STROKE; MANAGEMENT; IDARUCIZUMAB; RIVAROXABAN;
D O I
10.1136/jnnp-2017-316631
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction The characteristics and natural history of acute non-vitamin K antagonists oral anticoagulants (NOAC)-associated intracerebral haemorrhage (ICH) are largely unknown. We performed a comprehensive systematic review and meta-analysis to compare baseline ICH volume, haematoma expansion and clinical outcomes between NOAC-ICH versus vitamin K antagonists-ICH (VKA-ICH). Methods We searched PubMed and conference abstracts for observational studies comparing baseline characteristics and outcomes in patients with NOAC-ICH versus VKA-ICH using an appropriate keyword/MeSH term search strategy. Data were extracted following PRISMA and MOOSE guidelines. The main outcome measures were mortality and unfavourable functional outcome (modified Rankin Score: 4-6) at discharge and at 3 months, as well as ICH volumes and haematoma expansion rates in the two groups. Random-effects models with DerSimonian-Laird weights were used for pooled estimates calculation. Results Twelve studies including 393 NOAC-ICH and 3482 VKA-ICH were pooled in meta-analysis. There was no difference in mean ICH-volume between the two groups (standard mean difference:-0.24; 95% CI-0.52 to 0.04, p=0.093). The rates of haematoma expansion were comparable in NOAC-ICH versus VKA-ICH (OR: 0.76; 95% CI 0.49 to 1.19, p=0.236). We did not find any difference between patients with NOAC-ICH versus VKA-ICH in all-cause mortality at discharge (OR: 0.66; 95% CI 0.42 to 1.05, p=0.077) and unfavourable functional outcome at discharge (OR: 0.77; 95% C I 0.41 to 1.44, p=0.413). The 3-month outcome was also comparable between the two ICH groups. Moderate-tosubstantial statistical heterogeneity was noted. Conclusion Our results confirm that ICH volume, haematoma expansion, mortality and functional outcome appear to be similar for NOAC-ICH versus VKA-ICH. Large prospective cohorts and updated meta-analyses are needed to provide more precise estimates.
引用
收藏
页码:263 / 270
页数:8
相关论文
共 35 条
[1]  
Adachi T, 2017, CEREBROVASC DIS EXTR, V7, P62, DOI 10.1159/000462985
[2]   Characteristics of Symptomatic Intracranial Hemorrhage in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulant Therapy [J].
Akiyama, Hisanao ;
Uchino, Kenji ;
Hasegawa, Yasuhiro .
PLOS ONE, 2015, 10 (07)
[3]   Intracranial Hemorrhage Mortality in Atrial Fibrillation Patients Treated With Dabigatran or Warfarin [J].
Alonso, Alvaro ;
Bengtson, Lindsay G. S. ;
MacLehose, Richard F. ;
Lutsey, Pamela L. ;
Chen, Lin Y. ;
Lakshminarayan, Kamakshi .
STROKE, 2014, 45 (08) :2286-2291
[4]  
[Anonymous], STROKE
[5]  
[Anonymous], STROKE
[6]  
[Anonymous], AM AC NEUR ANN M
[7]   New Oral Anticoagulants and the Risk of Intracranial Hemorrhage Traditional and Bayesian Meta-analysis and Mixed Treatment Comparison of Randomized Trials of New Oral Anticoagulants in Atrial Fibrillation [J].
Chatterjee, Saurav ;
Sardar, Partha ;
Biondi-Zoccai, Giuseppe ;
Kumbhani, Dharam J. .
JAMA NEUROLOGY, 2013, 70 (12) :1486-1490
[8]   Novel Oral Anticoagulants in Atrial Fibrillation: A Meta-analysis of Large, Randomized, Controlled Trials vs Warfarin [J].
Dogliotti, Ariel ;
Paolasso, Ernesto ;
Giugliano, Robert P. .
CLINICAL CARDIOLOGY, 2013, 36 (02) :61-67
[9]   Defining hematoma expansion in intracerebral hemorrhage Relationship with patient outcomes [J].
Dowlatshahi, D. ;
Demchuk, A. M. ;
Flaherty, M. L. ;
Ali, M. ;
Lyden, P. L. ;
Smith, E. E. .
NEUROLOGY, 2011, 76 (14) :1238-1244
[10]   Poor Prognosis in Warfarin-Associated Intracranial Hemorrhage Despite Anticoagulation Reversal [J].
Dowlatshahi, Dar ;
Butcher, Kenneth S. ;
Asdaghi, Negar ;
Nahirniak, Susan ;
Bernbaum, Manya L. ;
Giulivi, Antonio ;
Wasserman, Jason K. ;
Poon, Man-Chiu ;
Coutts, Shelagh B. .
STROKE, 2012, 43 (07) :1812-1817